Skip to main content
FNIH Logo
FNIH Logo
Home

Main navigation

  • Our Value
    • Advancing Biomedical Innovation
    • Why Our Work Matters
    • Our Promise
  • Our Programs
    • All Programs
    • Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)
    • Accelerating Medicines Partnership® Program (AMP)
    • Awards, Prizes, and Events
    • Biomarkers Consortium
    • GeneConvene Global Collaborative
  • Our People
    • Board of Directors and Governance
    • Staff
  • Let's Collaborate
    • Advancing Research
    • Advancing Scientists
    • Advancing Our Shared Mission

Utility

  • News
    • Press Releases
    • Announcements
    • Digital Timeline
  • Careers
  • Donate
Patient Support
Research

Prevention of Iron Deficiency Anemia Post-Delivery (PRIORITY)

Research

Accelerating Medicines Partnership® Heart Failure

Research

Accelerating Medicines Partnership® (AMP®) Data Portals

Research

Accelerating Medicines Partnership® (AMP®) Projects

Research

HIV-Specific Adoptive T Cell Therapy to Target Viral Reservoirs

Research

Convening Experts in Oncology to Address Children's Health (COACH)

Research

Pre-competitive Analytical Validation of SV2A PET as a Biomarker of Synaptic Density (SV2A PET Project)

Research

Structure-Based Vaccine Design against HIV-1

Research

Combining Epitope-Based Vaccine Design with Informatics-Based Evaluation to Obtain a Universal Influenza Vaccine

Research

HIV Vaccine Development Using Virus-Like Particles

Pagination

  • Page 1
  • Next page ››
Subscribe to Research

Follow Us

  • Facebook
  • Twitter
  • Youtube
  • LinkedIn

Footer

  • Privacy Policy
  • Terms of Use
  • State Nonprofit Disclosures
  • NIH
  • Financials & Annual Reports
  • Equity, Diversity and Inclusion
  • Contact

Four Stars from Charity Navigator